BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases.Pediatrics. 1997;99:289-299. [PMID: 9024464 DOI: 10.1542/peds.99.2.289] [Cited by in Crossref: 124] [Cited by in F6Publishing: 72] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Kellner JD, Mcgeer A, Cetron MS, Low DE, Butler JC, Matlow A, Talbot J, Ford-jones EL. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease: . The Pediatric Infectious Disease Journal 1998;17:279-86. [DOI: 10.1097/00006454-199804000-00004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 2.8] [Reference Citation Analysis]
2 Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Viladrich PF, Gudiol F. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 2006;57:931-6. [DOI: 10.1093/jac/dkl047] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
3 Manoharan A, Jayaraman R. Pneumococcal vaccines. Indian J Med Microbiol 2018;36:465-74. [PMID: 30880692 DOI: 10.4103/ijmm.IJMM_18_442] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Caspary H, Welch JC, Lawson L, Darrow D, Buescher S, Shahab S, Derkay CS. Impact of Pneumococcal Polysaccharide Vaccine (Prevnar) on Middle Ear Fluid in Children Undergoing Tympanostomy Tube Insertion: . The Laryngoscope 2004;114:975-80. [DOI: 10.1097/00005537-200406000-00004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Tan TQ. Pneumococcal conjugate vaccines — implications for community antibiotic prescribing. Current Opinion in Microbiology 2000;3:502-7. [DOI: 10.1016/s1369-5274(00)00130-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Rafei K, Lichenstein R. Airway Infectious Disease Emergencies. Pediatric Clinics of North America 2006;53:215-42. [DOI: 10.1016/j.pcl.2005.10.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
7 Baraff LJ. Management of fever without source in infants and children. Annals of Emergency Medicine 2000;36:602-14. [DOI: 10.1067/mem.2000.110820] [Cited by in Crossref: 164] [Cited by in F6Publishing: 129] [Article Influence: 7.8] [Reference Citation Analysis]
8 Sarlangue J, Castella C, Lehours P. [First and second line antibiotic therapy for bacterial meningitis in infants and children]. Med Mal Infect 2009;39:521-30. [PMID: 19409744 DOI: 10.1016/j.medmal.2009.02.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Klein JO. Protecting the therapeutic advantage of antimicrobial agents used for otitis media: . The Pediatric Infectious Disease Journal 1998;17:571-5. [DOI: 10.1097/00006454-199806000-00038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
10 Pírez MC, Martínez O, Ferrari AM, Nairac A, Montano A, Rubio I, Saráchaga MJ, Brea S, Picon T, Pinchack MC, Torello P, Algorta G, Mogdasy MC. Standard case management of pneumonia in hospitalized children in Uruguay, 1997 to 1998. Pediatr Infect Dis J 2001;20:283-9. [PMID: 11303831 DOI: 10.1097/00006454-200103000-00013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
11 Wang XL, Du Y, Zhao CG, Wu YB, Yang N, Pei L, Wang LJ, Wang QS. Streptococcal pneumonia-associated hemolytic uremic syndrome treated by T-antibody-negative plasma exchange in children: Two case reports. World J Clin Cases 2021; 9(27): 8164-8170 [PMID: 34621876 DOI: 10.12998/wjcc.v9.i27.8164] [Reference Citation Analysis]
12 Granström G. Middle ear infections. Periodontol 2000 2009;49:179-93. [PMID: 19152534 DOI: 10.1111/j.1600-0757.2008.00281.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Fitoussi F, Doit C, Geslin P, Bingen E. Killing Activities of Trovafloxacin Alone and in Combination with β-Lactam Agents, Rifampin, or Vancomycin against Streptococcus pneumoniae Isolates with Various Susceptibilities to Extended-Spectrum Cephalosporins at Concentrations Clinically Achievable in Cerebrospinal Fluid. Antimicrob Agents Chemother 1999;43:2372-5. [DOI: 10.1128/aac.43.10.2372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sabella C, Goldfarb J. Principles of selection and use of antimicrobial agents. Seminars in Pediatric Infectious Diseases 1999;10:3-13. [DOI: 10.1016/s1045-1870(99)80004-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Halasa NB, Griffin MR, Zhu Y, Edwards KM. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age: . The Pediatric Infectious Disease Journal 2002;21:1023-8. [DOI: 10.1097/00006454-200211000-00009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
16 Moraga Llop F. La enfermedad neumocócica y su prevención. Vacuna neumocócica conjugada heptavalente. Anales de Pediatría 2002;56:79-90. [DOI: 10.1016/s1695-4033(02)77779-5] [Cited by in Crossref: 17] [Article Influence: 0.9] [Reference Citation Analysis]
17 Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet 2004;363:465-73. [PMID: 14962529 DOI: 10.1016/S0140-6736(04)15495-0] [Cited by in Crossref: 373] [Cited by in F6Publishing: 120] [Article Influence: 21.9] [Reference Citation Analysis]
18 Tan TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 2003;16:271-7. [PMID: 12821820 DOI: 10.1097/00001432-200306000-00015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
19 Choi S, Chung J, Kim B, Kwak YG, Kim TH, Lee EJ, Choo EJ, Jeon M, Lee MS, Bae I, Lee S, Song EH, Jun J, Kim M, Kim S, Lee S, Kim YS, Woo JH, Choi S. Clinical implication of extended-spectrum cephalosporin nonsusceptibility in Streptococcus pneumoniae meningitis. Eur J Clin Microbiol Infect Dis 2012;31:3029-34. [DOI: 10.1007/s10096-012-1657-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Bennett J, St. Geme JW. BACTERIAL RESISTANCE AND ANTIBIOTIC USE IN THE EMERGENCY DEPARTMENT. Pediatric Clinics of North America 1999;46:1125-43. [DOI: 10.1016/s0031-3955(05)70178-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 San Joaquin VH, Stull TL. ANTIBACTERIAL AGENTS IN PEDIATRICS. Infectious Disease Clinics of North America 2000;14:341-55. [DOI: 10.1016/s0891-5520(05)70251-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
22 Bourrillon A, Bingen E. Stratégie thérapeutique des méningites à pneumocoque résistant à la pénicilline en pédiatrie. Médecine et Maladies Infectieuses 2002;32:55-60. [DOI: 10.1016/s0399-077x(02)80008-7] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
23 Olivier C, Cohen R, Begué P, Floret D. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 2000;19:1015-7. [PMID: 11055609 DOI: 10.1097/00006454-200010000-00018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ahmed A. A critical evaluation of vancomycin for treatment of bacterial meningitis. Pediatr Infect Dis J 1997;16:895-903. [PMID: 9306486 DOI: 10.1097/00006454-199709000-00014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
25 Morita JY, Zell ER, Danila R, Farley MM, Hadler J, Harrison LH, Lefkowitz L, Reingold A, Kupronis BA, Schuchat A, Whitney CG. Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis 2002;35:420-7. [PMID: 12145726 DOI: 10.1086/341897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
26 Levy SB. Antibiotic and antiseptic resistance: impact on public health. Pediatr Infect Dis J 2000;19:S120-2. [PMID: 11052402 DOI: 10.1097/00006454-200010001-00008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 3.6] [Reference Citation Analysis]
27 Yin CC, Huah LW, Lin JTP, Goh A, Ling H, Moh CO. Lower respiratory tract infection in hospitalized children. Respirology 2003;8:83-9. [DOI: 10.1046/j.1440-1843.2003.00430.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
28 Mclure JM. A 9-Month-Old Boy with Fever and Lethargy. Clin Pediatr (Phila) 2000;39:295-8. [DOI: 10.1177/000992280003900507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Roberts RB, Tomasz A, Corso A, Hargrave J, Severina E; PRP Collaborative Study Group. Penicillin-resistant Streptococcus pneumoniae in metropolitan New York hospitals: case control study and molecular typing of resistant isolates. Microb Drug Resist 2001;7:137-52. [PMID: 11442340 DOI: 10.1089/10766290152045011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Esposito S, Principi N. Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children. Drug Resist Updat 2002;5:73-87. [PMID: 12135583 DOI: 10.1016/s1368-7646(02)00018-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Floret D. Méningite à pneumocoque et résistance bactérienne. Archives de Pédiatrie 2002;9:1166-72. [DOI: 10.1016/s0929-693x(02)00078-7] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
32 Ricard JD, Wolff M, Lacherade JC, Mourvillier B, Hidri N, Barnaud G, Chevrel G, Bouadma L, Dreyfuss D. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007;44:250-5. [PMID: 17173226 DOI: 10.1086/510390] [Cited by in Crossref: 95] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
33 Principi N, Esposito S. Paediatric community-acquired pneumonia: current concept in pharmacological control. Expert Opin Pharmacother 2003;4:761-77. [PMID: 12739999 DOI: 10.1517/14656566.4.5.761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
34 Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A. Clinical Outcomes of Meningitis Caused by Streptococcus pneumoniae in the Era of Antibiotic Resistance. Clinical Infectious Diseases 2000;30:71-7. [DOI: 10.1086/313606] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
35 Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L. Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Current Opinion in Pediatrics 2013;25:203-8. [DOI: 10.1097/mop.0b013e32835d7f2c] [Cited by in Crossref: 67] [Cited by in F6Publishing: 23] [Article Influence: 8.4] [Reference Citation Analysis]
36 Adler-shohet F, Lieberman JM. Bacterial pneumonia in children. Seminars in Pediatric Infectious Diseases 1998;9:191-8. [DOI: 10.1016/s1045-1870(98)80031-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
37 Mcdowell L, Kim B, Paterson D. Ceftriaxone. Kucers' The Use of Antibiotics Sixth Edition. CRC Press; 2010. pp. 351-89. [DOI: 10.1201/b13787-32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Odio CM, Puig JR, Feris JM, Khan WN, Rodriguez WJ, McCracken GH Jr, Bradley JS. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J 1999;18:581-90. [PMID: 10440432 DOI: 10.1097/00006454-199907000-00004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
39 Deghmane A, Alonso J, Taha M. Emerging drugs for acute bacterial meningitis. Expert Opinion on Emerging Drugs 2009;14:381-93. [DOI: 10.1517/14728210903120887] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
40 Mitchell LS, Tuomanen EI. Molecular analysis of antibiotic tolerance in pneumococci. International Journal of Medical Microbiology 2002;292:75-9. [DOI: 10.1078/1438-4221-00193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Esposito S, Principi N. Pharmacotherapy for pneumococcal infections: an update. Expert Opin Pharmacother 2013;14:65-77. [PMID: 23256539 DOI: 10.1517/14656566.2013.756867] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
42 Kellner JD, Scheifele DW, Halperin SA, Lebel MH, Moore D, Le Saux N, Ford-Jones EL, Law B, Vaudry W; Canadian Paediatric Society/Centre for Infectious Disease Prevention and Control Immunization Monitoring Program. Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J 2002;21:903-10. [PMID: 12394810 DOI: 10.1097/00006454-200210000-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
43 Munoz FM. Emergent antimicrobial-resistant pathogens in the pediatric intensive care unit. Seminars in Pediatric Infectious Diseases 1999;10:243-8. [DOI: 10.1016/s1045-1870(99)80031-4] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
44 Lichenstein R, Suggs AH, Campbell J. Pediatric pneumonia. Emergency Medicine Clinics of North America 2003;21:437-51. [DOI: 10.1016/s0733-8627(03)00008-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Wong W. Prevention and Management of Infection in Children with Sickle Cell Anaemia: . Paediatric Drugs 2001;3:793-801. [DOI: 10.2165/00128072-200103110-00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
46 Drusano G, Lode H, Edwards J. Meropenem: clinical response in relation to in vitro susceptibility. Clinical Microbiology and Infection 2000;6:185-94. [DOI: 10.1046/j.1469-0691.2000.00062.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
47 Hosein I, Hill D, Jenkins L, Magee J. Clinical significance of the emergence of bacterial resistance in the hospital environment: ANTIBIOTIC RESISTANCE IN HOSPITALS. Journal of Applied Microbiology 2002;92:90S-7S. [DOI: 10.1046/j.1365-2672.92.5s1.1.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
48 Morris A, Kellner JD, Low DE. The superbugs: evolution, dissemination and fitness. Curr Opin Microbiol 1998;1:524-9. [PMID: 10066531 DOI: 10.1016/s1369-5274(98)80084-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
49 Feigin RD, Cutrer WB. BACTERIAL MENINGITIS BEYOND THE NEONATAL PERIOD. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier; 2009. pp. 439-71. [DOI: 10.1016/b978-1-4160-4044-6.50042-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Cannon ML, Antonio BL, McCloskey JJ, Hines MH, Tobin JR, Shetty AK. Cavernous sinus thrombosis complicating sinusitis. Pediatr Crit Care Med 2004;5:86-8. [PMID: 14697115 DOI: 10.1097/01.PCC.0000102385.95708.3B] [Cited by in Crossref: 50] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
51 English BK, Buckingham SC. Impact of antimicrobial resistance on therapy of bacterial pneumonia in children. Adv Exp Med Biol 2006;582:125-35. [PMID: 16802624 DOI: 10.1007/0-387-33026-7_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
52 Jacobs MR. Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance. J Pediatr 2002;141:287-93. [PMID: 12183732 DOI: 10.1067/mpd.2002.125730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
53 Gómez-barreto D, Calderón-jaimes E, Rodrı́guez RS, de los Monteros LEE. Clinical Outcome of Invasive Infections in Children Caused by Highly Penicillin-Resistant Streptococcus pneumoniae Compared with Infections Caused by Penicillin-Susceptible Strains. Archives of Medical Research 2000;31:592-8. [DOI: 10.1016/s0188-4409(00)00244-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Sutton DV, Derkay CS, Darrow DH, Strasnick B. Resistant Bacteria in Middle Ear Fluid at the Time of Tympanotomy Tube Surgery. Ann Otol Rhinol Laryngol 2000;109:24-9. [DOI: 10.1177/000348940010900104] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
55 Holston AM, Miller JR. Primary lung abscess caused by multidrug-nonsusceptible Streptococcus pneumoniae in a child. Pediatr Infect Dis J 2006;25:182-3. [PMID: 16462303 DOI: 10.1097/01.inf.0000199320.87812.d9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
56 Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284. [PMID: 15494903 DOI: 10.1086/425368] [Cited by in Crossref: 1286] [Cited by in F6Publishing: 921] [Article Influence: 75.6] [Reference Citation Analysis]
57 File TM Jr. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;34 Suppl 1:S17-26. [PMID: 11810607 DOI: 10.1086/324526] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
58 Dagan R, Bhutta ZA, de Quadros CA, Garau J, Klugman KP, Khuri-bulos N, Levine O, Saha SK, Sow S, Were F, Yang Y. The Remaining Challenge of Pneumonia: The Leading Killer of Children. Pediatric Infectious Disease Journal 2011;30:1-2. [DOI: 10.1097/inf.0b013e3182005389] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
59 Sabella C, Goldfarb J. Penicillin-Resistant Pneumococcal Infections. Clin Pediatr (Phila) 1999;38:609-10. [DOI: 10.1177/000992289903801007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Low D. The new oral cephalosporins in community-acquired infections. Clinical Microbiology and Infection 2000;6:64-9. [DOI: 10.1111/j.1469-0691.2000.tb02047.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
61 Dowell SF. Antimicrobial resistance: is it really that bad? Seminars in Pediatric Infectious Diseases 2004;15:99-104. [DOI: 10.1053/j.spid.2004.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
62 Johnson AP, Potz N, Waight P, Gungabissoon U, Livermore DM, Pebody R, Miller E, George RC. Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004. J Antimicrob Chemother 2005;56:1181-2. [PMID: 16219757 DOI: 10.1093/jac/dki381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kaplan SL, Mason EO. Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998;11:628-44. [DOI: 10.1128/cmr.11.4.628] [Cited by in Crossref: 159] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
64 Lee H, Song J, Kim SW, Oh WS, Jung SI, Kiem S, Peck KR, Lee NY. Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis. International Journal of Antimicrobial Agents 2004;23:306-9. [DOI: 10.1016/j.ijantimicag.2003.07.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
65 Ball P. Therapy for pneumococcal infection at the millennium: doubts and certainties. Am J Med 1999;107:77S-85S. [PMID: 10451013 DOI: 10.1016/s0002-9343(99)00104-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
66 Harwell JI, Brown RB. The Drug-Resistant Pneumococcus. Chest 2000;117:530-41. [DOI: 10.1378/chest.117.2.530] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB; Linezolid Pediatric Study Group. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 2003;22:677-86. [PMID: 12913766 DOI: 10.1097/01.inf.0000078160.29072.42] [Cited by in Crossref: 128] [Cited by in F6Publishing: 101] [Article Influence: 7.1] [Reference Citation Analysis]
68 Mohan PV, Heath PT. Pneumococcal disease in childhood. Hosp Med 2001;62:406-9. [PMID: 11480127 DOI: 10.12968/hosp.2001.62.7.1609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
69 Rowland KE, Turnidge JD. The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. Aust N Z J Med 2000;30:441-9. [PMID: 10985508 DOI: 10.1111/j.1445-5994.2000.tb02049.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
70 Wald ER, Mason EO Jr, Bradley JS, Barson WJ, Kaplan SL; US Pediatric Multicenter Pneumococcal Surveillance Group. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J 2001;20:34-9. [PMID: 11176564 DOI: 10.1097/00006454-200101000-00007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
71 Leggiadro RJ. Penicillin-nonsusceptible Pneumococcus. Int J Antimicrob Agents 2000;14:123-7. [PMID: 10720802 DOI: 10.1016/s0924-8579(99)00171-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Qazi S. Short-Course Therapy for Community-Acquired Pneumonia in Paediatric Patients: . Drugs 2005;65:1179-92. [DOI: 10.2165/00003495-200565090-00001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]